Sleep medicine
-
Randomized Controlled Trial Multicenter Study
A 12-week open-label, multicenter study evaluating the safety and patient-reported efficacy of sodium oxybate in patients with narcolepsy and cataplexy.
This study aimed to evaluate safety and efficacy of sodium oxybate (SXB) titrated to effect. ⋯ The SXB safety profile was consistent with parent trials. Ninety percent of patients reported improvements as measured by the NSAQ.